Published in Gene Therapy Weekly, May 20th, 1996
The trial tests the company's commercial approach to this therapy, in which a patient's own T cells are collected, genetically modified to recognize and destroy HIV infected cells and returned to that same patient as AIDS gene therapy.
Drs. Steven Deeks and Paul Volberding, clinical investigators at the University of California, San Francisco and San...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.